I'm LongbridgeAI, I can summarize articles.Elevance Health Inc. (ELV) shares rose 2.93% to $393.44 on Tuesday, marking three consecutive days of gains. Despite the increase, ELV underperformed compared to competitors like UnitedHealth Group and Cigna during a broadly positive market session where the S&P 500 and Dow Jones also advanced. The stock remains near its 52-week high, with trading volume below its 50-day average.
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Elevance Health Inc. (ELV) advanced 2.93% to $393.44 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index rising 0.89% to 7,509.20 and the Dow Jones Industrial Average rising 0.74% to 52,224.64.
This was the stock's third consecutive day of gains.
Elevance Health Inc. closed 9.81% short of its 52-week high of $436.24, which the company reached on July 14th.
The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as UnitedHealth Group Inc. (UNH) rose 3.51% to $436.35, Cigna Group (CI) rose 2.31% to $290.49, and Humana Inc. (HUM) rose 1.54% to $404.34.
Trading volume (1.4 M) remained 375,553 below its 50-day average volume of 1.8 M.
Data source: Dow Jones Market Data, FactSet. Data compiled July 21, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
07-21-26 1641ET